|Articles|May 1, 2005
- Pharmaceutical Executive-05-01-2005
- Volume 0
- Issue 0
TOC
TOC
Advertisement
Articles in this issue
almost 21 years ago
Pharm Exec Ad Starsalmost 21 years ago
Elephant or Specialist?almost 21 years ago
Global Report: Iron Fistalmost 21 years ago
Washington Report: The Pendulum Swingsalmost 21 years ago
What Does It Take to be a Global Leader in Trainingalmost 21 years ago
Unleash the Tabletsalmost 21 years ago
Eisai's New Leadershipalmost 21 years ago
Superstar Selectionalmost 21 years ago
TOCalmost 21 years ago
Professional Persuasion:101Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5